Multi-organ Transit Time Acquisition Using Contrast Ultrasound

NCT05135169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2025-07-09

No results posted yet for this study

Summary

Echocardiographic contrast will be administered to volunteers for the purpose of measuring transit time through various organs/vascular beds

Conditions

  • Healthy

Interventions

DRUG

Definity Suspension for Injection

Administration of Definity

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-03
Primary Completion
2023-06-16
Completion
2025-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05135169 on ClinicalTrials.gov